The new HealthTech Fund will operate alongside Pitango's Early Stage
Tech and Growth funds, it said.
In its first investment, the fund will invest $7 million in
Variantyx, which has developed genomics diagnostics technologies.
Pitango said the fund's investments will focus on ventures in
digital health, health IT and medical technologies, as well as
diagnostics, biopharma, food technologies and agricultural
technologies.
[to top of second column] |
"We are witnessing incredible technological breakthroughs alongside
the challenge to find cost-effective solutions for the soaring costs
of healthcare," said Guy Ezekiel, Pitango's general partner.
"This creates outstanding opportunities for Pitango to further
develop our healthcare portfolio to a point where it deserves its
own dedicated fund."
(Reporting by Steven Scheer)
[© 2019 Thomson Reuters. All rights
reserved.] Copyright 2019 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content. |